{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:58:24Z","timestamp":1780678704732,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005270","name":"Science and Technology Program of Fujian Province, China","doi-asserted-by":"publisher","award":["2018Y2003"],"award-info":[{"award-number":["2018Y2003"]}],"id":[{"id":"10.13039\/501100005270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.bbrc.2020.03.087","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T20:00:26Z","timestamp":1586376026000},"page":"857-864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["LncRNA TLR8-AS1 promotes metastasis and chemoresistance of ovarian cancer through enhancing TLR8 mRNA stability"],"prefix":"10.1016","volume":"526","author":[{"given":"Qin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8177-8479","authenticated-orcid":false,"given":"Yi-Bin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.03.087_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.semcancer.2017.04.009","article-title":"Ovarian cancer stem cells more questions than answers","volume":"44","author":"Ottevanger","year":"2017","journal-title":"Semin. Canc. Biol."},{"key":"10.1016\/j.bbrc.2020.03.087_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx443","article-title":"Real-world evidence in the treatment of ovarian cancer","volume":"28","author":"Eisenhauer","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbrc.2020.03.087_bib3","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.ymthe.2017.04.016","article-title":"lncRNA HOXD-AS1 regulates proliferation and chemo-resistance of castration-resistant prostate cancer via recruiting WDR5","volume":"25","author":"Gu","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2020.03.087_bib4","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.7150\/thno.25541","article-title":"Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19","volume":"8","author":"Ren","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.bbrc.2020.03.087_bib5","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1172\/JCI91553","article-title":"JAK2-binding long noncoding RNA promotes breast cancer brain metastasis","volume":"127","author":"Wang","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2020.03.087_bib6","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00018-019-03018-3","article-title":"The functional roles of exosomal long non-coding RNAs in cancer","volume":"76","author":"Wang","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2020.03.087_bib7","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/s41467-017-01781-0","article-title":"Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition","volume":"8","author":"Mitra","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2020.03.087_bib8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-017-0709-5","article-title":"Role of the lncRNA ABHD11-AS1 in the tumorigenesis and progression of epithelial ovarian cancer through targeted regulation of RhoC","volume":"16","author":"Wu","year":"2017","journal-title":"Mol. Canc."},{"key":"10.1016\/j.bbrc.2020.03.087_bib9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbrc.2018.11.006","article-title":"LncRNA LINC00319 accelerates ovarian cancer progression through miR-423-5p\/NACC1 pathway","volume":"507","author":"Du","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2020.03.087_bib10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41419-018-1148-y","article-title":"The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2020.03.087_bib11","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/sj.bjc.6604803","article-title":"Efficacy assessment of sustained intraperitoneal paclitaxel therapy in a murine model of ovarian cancer using bioluminescent imaging","volume":"99","author":"Vassileva","year":"2008","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.bbrc.2020.03.087_bib12","doi-asserted-by":"crossref","first-page":"12507","DOI":"10.1074\/jbc.M113.538009","article-title":"Interleukin-1 receptor-associated kinase-2 genetic variant rs708035 increases NF-kappaB activity through promoting TRAF6 ubiquitination","volume":"289","author":"Zhang","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.03.087_bib13","article-title":"1,25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in\u00a0vitro and experimental autoimmune encephalomyelitis in\u00a0vivo","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2020.03.087_bib14","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.7150\/thno.37717","article-title":"HBX-induced miR-5188 impairs FOXO1 to stimulate beta-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma","volume":"9","author":"Lin","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bbrc.2020.03.087_bib15","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1172\/JCI36551","article-title":"Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance","volume":"120","author":"Cherfils-Vicini","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2020.03.087_bib16","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","article-title":"Long noncoding RNA and cancer: a new paradigm","volume":"77","author":"Bhan","year":"2017","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2020.03.087_bib17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12967-018-1640-2","article-title":"Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer","volume":"16","author":"Fan","year":"2018","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.bbrc.2020.03.087_bib18","article-title":"Identification of the complex regulatory relationships related to gastric cancer from lncRNA-miRNA-mRNA network","author":"Wang","year":"2019","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.bbrc.2020.03.087_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10549-019-05147-6","article-title":"An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network","volume":"175","author":"Sun","year":"2019","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.bbrc.2020.03.087_bib20","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1158\/0008-5472.CAN-16-1615","article-title":"Long noncoding RNA LINC00092 acts in cancer-associated fibroblasts to drive glycolysis and progression of ovarian cancer","volume":"77","author":"Zhao","year":"2017","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2020.03.087_bib21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3389\/fonc.2019.00739","article-title":"Long non-coding RNAs as communicators and mediators between the tumor microenvironment and cancer cells","volume":"9","author":"Chen","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2020.03.087_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010123","article-title":"Natural antisense transcripts: molecular mechanisms and implications in breast cancers","volume":"19","author":"Latge","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2020.03.087_bib23","first-page":"665","article-title":"Biological functions of natural antisense transcripts","volume":"63","author":"Rosikiewicz","year":"2016","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.bbrc.2020.03.087_bib24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/sj.onc.1210913","article-title":"TLR7 and TLR8 as targets in cancer therapy","volume":"27","author":"Schon","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2020.03.087_bib25","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1158\/1078-0432.CCR-16-1453","article-title":"Integrative development of a TLR8 agonist for ovarian cancer chemoimmunotherapy","volume":"23","author":"Monk","year":"2017","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2020.03.087_bib26","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1158\/1078-0432.CCR-16-1934","article-title":"Phase ib trial of the toll-like receptor 8 agonist, motolimod (VTX-2337), combined with cetuximab in patients with recurrent or metastatic SCCHN","volume":"23","author":"Chow","year":"2017","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.bbrc.2020.03.087_bib27","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1158\/1078-0432.CCR-14-0392","article-title":"A\u00a0phase I dose-finding study of the novel Toll-like receptor 8 agonist VTX-2337 in adult subjects with advanced solid tumors or lymphoma","volume":"20","author":"Northfelt","year":"2014","journal-title":"Clin. Canc. Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20305726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20305726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:51:51Z","timestamp":1757764311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X20305726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0006291X20305726"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.03.087","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LncRNA TLR8-AS1 promotes metastasis and chemoresistance of ovarian cancer through enhancing TLR8 mRNA stability","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.03.087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}